Delivering affordable, high-quality medicines
Sandoz, the generic pharmaceuticals division of Novartis, is a global industry leader, offering affordable, high-quality medicines. It is the third-largest division of Novartis, representing 16.2% of the Group’s total net sales.
2011 net sales - USD 9.5 billion
Sandoz develops, produces and markets approximately 1 000 compounds across all major therapeutic areas, as well as biopharmaceuticals, active substances and intermediates. Its operations span five continents, and it markets products in about 130 countries.
In addition to its retail generics business, Sandoz also operates anti-infectives and biopharmaceuticals & oncology injectables businessess, where it has a strong leadership position.
Not all products or indications are available in all countries. Regulatory requirements in various countries limit the product information that we can provide. Please consult your healthcare professional about any medical condition or product.
|Enoxaparin sodium injection||Lovenox®||Anti-coagulant|
|Amoxicillin / clavulanic acid||Augmentin®
(Procter & Gamble)
|Ulcer and heartburn treatment|
|Lansoprazole||Prevacid®||Proton pump inhibitor|
|Omnitrope||Genotropin®||Human growth hormone|
(Merck & Co)
- *Product names identified by a "®" are trademarks that are not owned by or licensed to the Novartis Group of companies.